Lot numbers can be found on the outside label of a product:
6,8-Dibromoimidazo[1,2-a]pyrazine
-
CAS No. 63744-22-9
- Cat. No. CS-M3157
- Purity≥98%
- MDL No.MFCD08460056
*For research and further manufacturing use only, not for direct human use.
![6,8-Dibromoimidazo[1,2-a]pyrazine|CS-M3157](https://file.chemscene.com/productPIC/CS-M3157.gif)
Structure of 63744-22-9
Please choose your location and provide accurate information for you
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Recommended Products
General Information
- CAS No. 63744-22-9
- Cat. No. CS-M3157
- Purity ≥98%
- MDL No. MFCD08460056
- Storage 4°C
- Shipping Room temperature in continental US; may vary elsewhere.
- Molecular Formula C₆H₃Br₂N₃
- Molecular Weight 276.92
- Synonym(s) 6,8-Dibromimidazo[1,2-a]pyrazin
- SMILES BrC1=CN2C(C(Br)=N1)=NC=C2
Description
6,8-Dibromoimidazo[1,2-a]pyrazine is a brominated heterocyclic scaffold featuring two halogen substituents at positions 6 and 8. This electron-deficient core integrates readily into cross-coupling reactions, enabling efficient construction of complex polycyclic architectures. The molecule exhibits enhanced stability under standard conditions and serves as a key building block in the synthesis of bioactive compounds and functional materials.
Application
6,8-Dibromoimidazo[1,2-a]pyrazine serves as a versatile building block for heterocyclic synthesis, enabling direct functionalization in transition-metal-catalyzed cross-coupling reactions. Its brominated positions offer high reactivity and positional selectivity, facilitating the construction of complex polycyclic scaffolds relevant to medicinal chemistry. The compound exhibits excellent bench stability and ease of purification, making it well-suited for scalable synthetic applications.
Synthesis
-
Route1
-
In-stock
24241-18-7 -
2032-35-1 - ~99%
-
In-stock
63744-22-9
References
-
BAYER PHARMA AKTIENGESELLSCHAFT; KOPPITZ, Marcus; KLAR, Ulrich; JAUTELAT, Rolf; KOSEMUND, Dirk; BOHLMANN, Rolf; BADER, Benjamin; LIENAU, Philip; SIEMEISTER, Gerhard Patent: WO2012/80236 A1, 2012 ; Location in patent: Page/Page column 63 ; WO 2012/080236 A1
-
-
References
-
Oncotherapy Science, Inc. Patent: US2012/59162 A1, 2012 ; Location in patent: Page/Page column 53-54 ;
-
-
Route3
-
107-20-0
-
In-stock
24241-18-7
- ~88%
-
In-stock
63744-22-9
References
-
Belanger, David B.; Curran, Patrick J.; Hruza, Alan; Voigt, Johannes; Meng, Zhaoyang; Mandal, Amit K.; Siddiqui, M. Arshad; Basso, Andrea D.; Gray, Kimberly Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 17 p. 5170 - 5174
-
Safety Information
Download SDS|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H315-H319-H335
|
|
|
Precautionary Statements : P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
|
|
Quality Control
Computational Chemistry Data
- TPSA 30.19
- LogP 2.2543
- H_Acceptors 3
- H_Donors 0
- Rotatable_Bonds 0
Similar Products
Other Classifications
Recently Viewed Products
Leave US a Message
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Key Words
- 6,8-Dibromoimidazo[1,2-a]pyrazine sigma6,8-Dibromoimidazo[1,2-a]pyrazine manufacturer6,8-Dibromoimidazo[1,2-a]pyrazine price6,8-Dibromoimidazo[1,2-a]pyrazine structure6,8-Dibromoimidazo[1,2-a]pyrazine SDSbuy 6,8-Dibromoimidazo[1,2-a]pyrazine6,8-Dibromoimidazo[1,2-a]pyrazine supplier6,8-Dibromoimidazo[1,2-a]pyrazine uses6,8-Dibromoimidazo[1,2-a]pyrazine molecular weightprice of 6,8-Dibromoimidazo[1,2-a]pyrazine6,8-Dibromoimidazo[1,2-a]pyrazine chemical name formula of 6,8-Dibromoimidazo[1,2-a]pyrazine